Expected earnings - Passage Bio Inc.
Source: US Earnings Reports
Passage Bio Inc. (PASG) is expected to report $-4 for Q2 2025
Passage Bio Inc.
NASDAQ: PASG
PASG Trading
2.67% G/L:
$8.85 Last:
9,797 Volume:
$8.67 Open:
PASG Latest News
PASG Stock Data
$30,817,593
2,546,147
0.38%
18
N/A
Biotechnology & Life Sciences
Healthcare
US
Philadelphia
